Decreasing Mio levels results in abnormal myofibril ultrastructure. by Grzegorz L. Polak (787000)

Simvastatin decreases peroxynitrite, superoxide and iNOS production. by Mohammed Sabri (355717)

“…<b>D</b> and <b>E.</b> Western blot quantification of iNOS protein expression show that iNOS protein was significantly decreased by pre- (<b>D</b>, <i>P</i><0.01) but not post-SAH (<b>E</b>, <i>P></i>0.05) simvastatin treatment as compared to vehicle treated animals. …”

Imiquimod decreases DFTD cell number in culture in a concentration and time dependent manner. by Amanda L. Patchett (3391931)

CsA decreases renal host resistance to UPEC. by Emilie Tourneur (278826)

Solubility (Ksp), adsorption (Koc), time for 50% decomposition (<em>T</em>^1/2) and lethal dose-50 (LD-50) for pesticides used in two background and three beef-finishing... by P Modernel (557300)

“…</b>  Solubility (Ksp), adsorption (Koc), time for 50% decomposition (<em>T</em>^1/2) and lethal dose-50 (LD-50) for pesticides used in two background and three beef-finishing systems of eastern Uruguay. …”

Aberrant distribution of BDNF and decreased BDNF immunoreactivity in the cerebellum. by Tetsushi Sadakata (69782)

VGB decreased activation of the mTOR pathway in vivo. by Bo Zhang (6559)

Decreased astrocytosis in brains of high-dose treated mice. by Pamela J. Skinner (49026)

“…Levels of GFAP staining are shown for C) whole brain, D) hippocamus, and E) thalamus. The high-dose-treated mice showed a trend of less GFAP accumulation in the brain compared to mock-treated mice (<i>p</i> = 0.103 by a 2 sample <i>t</i>-test on the logarithms of the levels), whereas no difference was detected between the low-dose-treated and mock infected mice (<i>p</i> = 0.906 again by a 2 sample <i>t</i>-test). …”

Decreasing Pronephric Fluid Flow Suppresses Anterior Migration by Aleksandr Vasilyev (150743)

Decreasing Mio levels results in abnormal myofibril organization. by Grzegorz L. Polak (787000)

Decreasing medium osmolarity causes retraction as theoretically predicted. by Nikola Ojkic (651966)

VPA treatment and senescence induction is associated with decreased neurogenesis. by Muriel Rhinn (406515)

Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE^-/- mice by Julian Jehle (586001)

“…</p><p>Methods</p><p>The impact of 2-AG on atherogenesis was studied in two treatment groups of ApoE^-/- mice. …”

Histological abnormalities in E18.5 ATF2 mutant cerebellum and brainstem. by Julien Ackermann (223933)

“…(B) Area plot of the central canal (mean ± SEM of 3 brainstems analysed per genotype), measured along the antero-posterior axis of serial transversal sections from the obex (0 µm on the x-axis) posteriorly to the caudal end of the medulla, shows a significant enlargement of the canal in <i>Atf2^−/−</i> embryos. …”

Ectopic lesions are decreased in PUGKO mice compared to controls. by Jan Sunde (8837384)

“…<b>E.</b> Lesion count in mice with endometrial tissue from tdT mice ± progesterone on postnatal day 2–10 (PUGKO). …”

TNFα decreased Best-3 expression in endothelium. by Wei Song (30780)

“…<p>(<b>A</b>) quantitative PCR analysis of Best-1, Best-2 and Best-3 mRNA expression in HUVECs. n = 6. …”

Psychosocial stress a decreases the GFP expression in vivo. by Masayoshi Okada (288631)

“…(B and C) GFP expressions in the control (B) and isolated (C) rats pituitaries. Bar = 20 µm. (D and E) Isolation induced decrease in the GFP expression. …”

Inhibition of Hh signaling decreases hMSC proliferation. by Magali Plaisant (230886)

FHL2 silencing decreases osteosarcoma cell growth. by Julia Brun (286504)

Genes whose expression decreases with age in the human brain. by Mun-Gwan Hong (271202)